Classic view of this page
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next … see more Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing  see less
Clinical Genetic Test
Help
offered by
ARUP Laboratories, Molecular Oncology
View lab's test page
LinkOut
GTR Test Accession: Help GTR000613045.1
CANCERCONNECTIVE TISSUEHEMATOLOGY ... View more
Registered in GTR: 2023-10-23
View version history
Last annual review date for the lab: 2024-11-14 LinkOut
At a Glance
Test purpose: Help
Diagnosis; Monitoring; Predictive; ...
Conditions (6): Help
Acute myeloid leukemia; Chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myelomonocytic leukemia more...
Genes (65): Help
ANKRD26 (10p12.1); ASXL1 (20q11.21); ASXL2 (2p23.3); BCOR (Xp11.4); BCORL1 (Xq26.1) more...
Methods (2): Help
Molecular Genetics - Deletion/duplication analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS); ...
Target population: Help
Not provided
Clinical validity: Help
Not provided
Clinical utility: Help
Not provided
Ordering Information
Offered by: Help
ARUP Laboratories, Molecular Oncology
View lab's website
View lab's test page
Who can order: Help
  • Health Care Provider
Test Order Code: Help
3016621
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
How to Order, Specimen source, Lab contact for this test, Test strategy, Test development
Conditions Help
Total conditions: 6
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 65
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Deletion/duplication analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Monitoring; Predictive; Prognostic; Therapeutic management
Recommended fields not provided:
Clinical validity, Clinical utility, Target population, What is the protocol for interpreting a variation as a VUS?, Are family members with defined clinical status recruited to assess significance of VUS without charge?, Will the lab re-contact the ordering physician if variant interpretation changes?, Is research allowed on the sample after clinical testing is complete?, Sample negative report, Sample positive report
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
LIMIT OF DETECTION (LOD): 5 percent variant allele fraction (VAF) for single nucleotide variants (SNV) and small variants less than 24 base pairs (bp). Variants greater than 24 bp may be detected at LOD, but the analytical sensitivity may be reduced. LOD for CNVs is greater than2 Mb in size … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory
Recommended fields not provided:
Test Confirmation, Assay limitations, Description of internal test validation method, Citations for Analytical validity, PT Provider, Description of PT method, Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.